Charles River Laboratories International, Inc. (CRL)
USD 183.16
(-3.26%)
USD 183.16
(-3.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.06 Billion USD | -1.0% |
| 2022 | 3.09 Billion USD | 6.1% |
| 2021 | 2.91 Billion USD | 36.71% |
| 2020 | 2.13 Billion USD | 6.53% |
| 2019 | 2 Billion USD | 20.17% |
| 2018 | 1.66 Billion USD | 45.66% |
| 2017 | 1.14 Billion USD | -7.28% |
| 2016 | 1.23 Billion USD | 43.1% |
| 2015 | 863.03 Million USD | 10.95% |
| 2014 | 777.86 Million USD | 17.19% |
| 2013 | 663.78 Million USD | -0.41% |
| 2012 | 666.52 Million USD | -7.16% |
| 2011 | 717.94 Million USD | 2.44% |
| 2010 | 700.85 Million USD | 42.21% |
| 2009 | 492.83 Million USD | -14.45% |
| 2008 | 576.09 Million USD | 12.95% |
| 2007 | 510.04 Million USD | -10.84% |
| 2006 | 572.06 Million USD | 92.83% |
| 2005 | 296.66 Million USD | -56.81% |
| 2004 | 686.84 Million USD | 269.9% |
| 2003 | 185.68 Million USD | -3.53% |
| 2002 | 192.48 Million USD | 22.76% |
| 2001 | 156.8 Million USD | -22.73% |
| 2000 | 202.91 Million USD | -47.44% |
| 1999 | 386.04 Million USD | 24302.28% |
| 1998 | 1.58 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 3.08 Billion USD | 0.48% |
| 2024 Q2 | 2.84 Billion USD | -7.79% |
| 2023 Q2 | 3.08 Billion USD | -2.59% |
| 2023 FY | 3.06 Billion USD | -1.0% |
| 2023 Q3 | 2.9 Billion USD | -5.7% |
| 2023 Q1 | 3.16 Billion USD | 2.09% |
| 2023 Q4 | 3.06 Billion USD | 5.57% |
| 2022 Q3 | 3.35 Billion USD | -1.81% |
| 2022 Q1 | 2.98 Billion USD | 2.11% |
| 2022 FY | 3.09 Billion USD | 6.1% |
| 2022 Q4 | 3.09 Billion USD | -7.62% |
| 2022 Q2 | 3.41 Billion USD | 14.54% |
| 2021 Q2 | 2.96 Billion USD | 23.53% |
| 2021 Q4 | 2.91 Billion USD | -7.93% |
| 2021 FY | 2.91 Billion USD | 36.71% |
| 2021 Q1 | 2.4 Billion USD | 12.59% |
| 2021 Q3 | 3.17 Billion USD | 6.77% |
| 2020 Q4 | 2.13 Billion USD | -2.39% |
| 2020 Q1 | 2.53 Billion USD | 26.24% |
| 2020 Q3 | 2.18 Billion USD | -10.08% |
| 2020 Q2 | 2.43 Billion USD | -3.86% |
| 2020 FY | 2.13 Billion USD | 6.53% |
| 2019 Q3 | 2.05 Billion USD | -6.76% |
| 2019 Q2 | 2.2 Billion USD | 29.57% |
| 2019 FY | 2 Billion USD | 20.17% |
| 2019 Q4 | 2 Billion USD | -2.37% |
| 2019 Q1 | 1.69 Billion USD | 1.88% |
| 2018 Q1 | 1.13 Billion USD | -1.08% |
| 2018 Q3 | 1.68 Billion USD | -7.85% |
| 2018 Q4 | 1.66 Billion USD | -0.97% |
| 2018 FY | 1.66 Billion USD | 45.66% |
| 2018 Q2 | 1.82 Billion USD | 61.36% |
| 2017 Q2 | 1.14 Billion USD | -4.5% |
| 2017 Q4 | 1.14 Billion USD | -3.21% |
| 2017 FY | 1.14 Billion USD | -7.28% |
| 2017 Q1 | 1.19 Billion USD | -3.05% |
| 2017 Q3 | 1.18 Billion USD | 3.46% |
| 2016 Q2 | 1.36 Billion USD | 58.38% |
| 2016 FY | 1.23 Billion USD | 43.1% |
| 2016 Q3 | 1.25 Billion USD | -7.75% |
| 2016 Q4 | 1.23 Billion USD | -1.92% |
| 2016 Q1 | 861.86 Million USD | -0.14% |
| 2015 Q1 | 786.41 Million USD | 1.1% |
| 2015 FY | 863.03 Million USD | 10.95% |
| 2015 Q4 | 863.03 Million USD | 1.25% |
| 2015 Q3 | 852.39 Million USD | 10.3% |
| 2015 Q2 | 772.77 Million USD | -1.73% |
| 2014 Q1 | 640.81 Million USD | -3.46% |
| 2014 Q2 | 813.54 Million USD | 26.96% |
| 2014 FY | 777.86 Million USD | 17.19% |
| 2014 Q4 | 777.86 Million USD | -1.13% |
| 2014 Q3 | 786.71 Million USD | -3.3% |
| 2013 FY | 663.78 Million USD | -0.41% |
| 2013 Q3 | 640.48 Million USD | 0.71% |
| 2013 Q1 | 648.88 Million USD | -2.65% |
| 2013 Q2 | 635.93 Million USD | -2.0% |
| 2013 Q4 | 663.78 Million USD | 3.64% |
| 2012 Q2 | 686.22 Million USD | -2.57% |
| 2012 FY | 666.52 Million USD | -7.16% |
| 2012 Q1 | 704.31 Million USD | -1.9% |
| 2012 Q4 | 666.52 Million USD | -0.33% |
| 2012 Q3 | 668.74 Million USD | -2.55% |
| 2011 Q2 | 789.41 Million USD | -7.87% |
| 2011 Q4 | 717.94 Million USD | -3.02% |
| 2011 FY | 717.94 Million USD | 2.44% |
| 2011 Q1 | 856.82 Million USD | 22.25% |
| 2011 Q3 | 740.32 Million USD | -6.22% |
| 2010 Q2 | 436.21 Million USD | -8.02% |
| 2010 Q1 | 474.25 Million USD | -3.77% |
| 2010 FY | 700.85 Million USD | 42.21% |
| 2010 Q4 | 700.85 Million USD | -2.51% |
| 2010 Q3 | 718.89 Million USD | 64.8% |
| 2009 Q1 | 509.52 Million USD | -11.56% |
| 2009 FY | 492.83 Million USD | -14.45% |
| 2009 Q4 | 492.83 Million USD | -1.11% |
| 2009 Q3 | 498.34 Million USD | -4.51% |
| 2009 Q2 | 521.89 Million USD | 2.43% |
| 2008 Q3 | 542.71 Million USD | 3.91% |
| 2008 Q1 | 510.11 Million USD | 0.01% |
| 2008 FY | 576.09 Million USD | 12.95% |
| 2008 Q4 | 576.09 Million USD | 6.15% |
| 2008 Q2 | 522.3 Million USD | 2.39% |
| 2007 Q4 | 510.04 Million USD | -1.5% |
| 2007 Q1 | 553.31 Million USD | -3.28% |
| 2007 FY | 510.04 Million USD | -10.84% |
| 2007 Q3 | 517.83 Million USD | -3.37% |
| 2007 Q2 | 535.91 Million USD | -3.14% |
| 2006 Q1 | 307.05 Million USD | 3.5% |
| 2006 FY | 572.06 Million USD | 92.83% |
| 2006 Q4 | 572.06 Million USD | -4.76% |
| 2006 Q3 | 600.65 Million USD | -1.29% |
| 2006 Q2 | 608.53 Million USD | 98.18% |
| 2005 FY | 296.66 Million USD | -56.81% |
| 2005 Q4 | 296.66 Million USD | -21.58% |
| 2005 Q3 | 378.28 Million USD | -6.95% |
| 2005 Q2 | 406.54 Million USD | -39.02% |
| 2005 Q1 | 666.64 Million USD | -2.94% |
| 2004 FY | 686.84 Million USD | 269.9% |
| 2004 Q4 | 686.84 Million USD | 269.35% |
| 2004 Q3 | 185.96 Million USD | -0.36% |
| 2004 Q2 | 186.63 Million USD | 0.22% |
| 2004 Q1 | 186.22 Million USD | 0.29% |
| 2003 Q3 | 189.76 Million USD | -0.06% |
| 2003 Q4 | 185.68 Million USD | -2.15% |
| 2003 FY | 185.68 Million USD | -3.53% |
| 2003 Q2 | 189.86 Million USD | 0.01% |
| 2003 Q1 | 189.84 Million USD | -1.37% |
| 2002 Q1 | 262.65 Million USD | 67.51% |
| 2002 FY | 192.48 Million USD | 22.76% |
| 2002 Q4 | 192.48 Million USD | 2.07% |
| 2002 Q3 | 188.58 Million USD | -0.24% |
| 2002 Q2 | 189.04 Million USD | -28.02% |
| 2001 Q1 | 248.49 Million USD | 22.46% |
| 2001 Q2 | 202.55 Million USD | -18.49% |
| 2001 FY | 156.8 Million USD | -22.73% |
| 2001 Q3 | 194.64 Million USD | -3.91% |
| 2001 Q4 | 156.8 Million USD | -19.44% |
| 2000 Q3 | 203.09 Million USD | -49.23% |
| 2000 Q1 | 398.14 Million USD | 0.0% |
| 2000 Q2 | 400.01 Million USD | 0.47% |
| 2000 Q4 | 202.91 Million USD | -0.09% |
| 2000 FY | 202.91 Million USD | -47.44% |
| 1999 FY | 386.04 Million USD | 24302.28% |
| 1998 FY | 1.58 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Agilent Technologies, Inc. | 2.73 Billion USD | -12.116% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | 42.887% |
| Danaher Corporation | 19.53 Billion USD | 84.304% |
| Enzo Biochem, Inc. | 265 Thousand USD | -1157024.906% |
| IQVIA Holdings Inc. | 14.23 Billion USD | 78.453% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 48.501% |
| Mettler-Toledo International Inc. | 2.08 Billion USD | -47.363% |
| Qiagen N.V. | 1.61 Billion USD | -90.325% |
| Revvity, Inc. | 4.03 Billion USD | 23.956% |
| Thermo Fisher Scientific Inc. | 34.91 Billion USD | 91.218% |
| Waters Corporation | 2.35 Billion USD | -30.179% |